The product is a generic version of Jerome Stevens Pharmaceuticals Inc’s Unithroid tablets in the same strengths, it added.

According to IQVIA MAT June 2019 data, Levothyroxine Sodium tablets USP had total annual sales of about USD 2,581 million in the US, Lupin said.

The tablets are indicated for hypothyroidism and pituitary thyrotropin suppression, it added. Shares of Lupin Ltd closed at Rs 756 per scrip on the BSE, up 1.98 per cent from its previous close.Read More..